361 CAPITAL LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 276 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
361 CAPITAL LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2020$1,074,000
-13.2%
18,555
-19.2%
0.49%
+42.3%
Q4 2019$1,238,000
+2.6%
22,956
-3.9%
0.34%
+63.3%
Q1 2019$1,207,000
-21.8%
23,895
-21.8%
0.21%
-40.0%
Q2 2018$1,543,000
-0.8%
30,556
+3.4%
0.35%
-9.1%
Q1 2018$1,556,000
-36.4%
29,547
-43.9%
0.38%
-36.5%
Q4 2017$2,447,000
+1105.4%
52,662
+948.0%
0.61%
+1453.8%
Q3 2017$203,0005,0250.04%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,810,519$52,071,0004.06%
Avoro Capital Advisors LLC 330,635$9,509,0003.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 766,424$22,043,0001.32%
GREAT POINT PARTNERS LLC 102,791$2,956,0001.30%
Matarin Capital Management, LLC 75,380$2,167,929,0000.66%
GLOBEFLEX CAPITAL L P 89,151$2,564,0000.49%
LaSalle Street Capital Management, LLC 15,897$457,0000.45%
TFS CAPITAL LLC 149,318$4,294,0000.42%
TURNER INVESTMENTS LLC 71,880$2,067,0000.37%
NEW AMSTERDAM PARTNERS LLC/NY 136,116$3,915,0000.32%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders